Publication | Open Access
Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch
33
Citations
53
References
2022
Year
This study indicates the potential of combining (immuno)therapy with HDACi to enhance both T cell-driven and NKcell-driven immune responses in patients with HR-NBL.
| Year | Citations | |
|---|---|---|
Page 1
Page 1